The neuromuscular junction lies beyond the protective In recent years, two groups have found that GQ1b antibodies can cause blockage of neuromuscular transmission, security network of the blood-brain barrier and the connective suggesting that this may account for some of the motor tissue sheaths of peripheral nerves. This makes it vulnerable symptoms of MFS. Willison, in collaboration with Vincent to attack by a variety of foreign agents such as the bacterial and Newsom-Davis in Oxford and Plomp and Molenaar in toxin that causes botulism and the paralytic components of Leiden, have found that addition of anti-GQ1b antibodies to animal venoms such as α-latrotoxin, produced by the black the fluid bathing an isolated mouse muscle leads, in tens widow spider. In addition, homology between foreign of minutes, to a massive increase in the frequency of antigens and extracellular components of 'self' proteins spontaneous release of ACh quanta and eventual failure ('molecular mimicry') may result in autoantibodies of internal of evoked release, and thus of neuromuscular transmission. origin, arising during the normal defensive activity of the These effects are very reminiscent of those seen following immune system, acting as double agents by binding to application of α-latrotoxin (Roberts et al., 1994; Plomp et al. , normal components of the neuromuscular junction. In the 1999). Their more recent studies provide evidence that this Miller-Fisher syndrome (MFS), a variant of Guillain-Barré effect depends on calcium and involves complement, though syndrome characterized by ophthalmoplegia, areflexia and apparently not by activation of the 'classic pathway' or the ataxia, it has been known for some time that antibodies formation of a membrane attack complex. In this issue, against GQ1b gangliosides are generally present (reviewed they provide evidence of structural breakdown of the nerve in Willison and O'Hanlon, 1999) and that these antibodies terminal accompanying the loss of function (O'Hanlon et al., can bind to motor nerve terminals and disrupt their function 2001). This breakdown involves disruption of neurofilaments (Roberts et al., 1994; Buchwald et al., 1995) . This has and microtubules as well as envelopment of the degenerating led to the suggestion that impairment of neuromuscular nerve terminal by processes of Schwann cells. Their evidence transmission may lie at the heart of some of the motor suggests that this breakdown results from a complementsymptoms of MFS. In the present issue, O'Hanlon and mediated increase in the calcium permeability of the nerve colleagues take this evidence further with their report of terminal and the subsequent activation of calcium-dependent overt structural breakdown of the nerve terminal associated lytic enzymes in the axoplasm. How much of the terminal with the disruption of neuromuscular transmission by antiaxon degenerates is unclear, but a local breakdown, followed GQ1b antibodies in vitro (O'Hanlon et al., 2001) .
by rapid regeneration of the nerve, would be consistent with There is good evidence that the anti-GQ1b antibodies the known time course of reversal of some of the symptoms present in MFS are often elaborated against LPS sequences of MFS. on the bacterium Campylobacter jejuni, a common cause of In contrast to the results from Willison and colleagues, enteritis. It is generally believed that the distinctive Buchwald and colleagues have observed a rapid and reversible involvement of the extraocular muscles in MFS is a result block of the evoked release of ACh quanta and a reduction in of particularly high levels of GQ1b gangliosides in the their postsynaptic effect. They have used rapid application of cranial nerves that supply the eyes (Chiba et al., 1997), antibodies to a small part of the motor nerve terminal, observing although it is by no means clear that this is the whole story. significant effects within a few minutes (e.g. Buchwald et al., Neurophysiological studies have suggested that, while the 1995, 2001). These effects were dose-dependent and were seen functional defects in MFS are primarily sensory in the limbs, with purified IgG fractions that did not contain complement. they are predominantly motor in the extraocular muscles
The explanation for the differences in observations made by (Fross and Daube, 1987) . Immunolabelling studies have these two groups has not yet been resolved. One possibility is shown that anti-GQ1b antibodies bind both to nodes of that by applying antibodies to a small region of the neuroRanvier and to the neuromuscular junction. However, neither muscular junction for a short time, Buchwald and her the identity of the cellular components of the neuromuscular colleagues have been able to observe early, possibly transient junction to which the antibodies bind, nor the function of effects which do not occur, or are harder to see, with diffuse the molecular targets, is clearly established (Plomp et al., bath application. There are several precedents for a dual 1999; Bullens et al., 2000) . These findings raise the question action of agents that attack the nerve terminal. For example, of how antibody binding might lead to the various symptoms α-latrotoxin itself is known to act by at least two different mechanisms, one dependent on calcium and one not (reviewed of MFS. The overriding challenge for the immediate future is to 1035-43. determine the relevance of these observations on the action are bound to neuromuscular junctions in MFS patients. In the absence of such samples, which will be very hard to
